A manufacturer is reliable only when it can repeatedly deliver the right medicine, at the stated strength and purity, in the correct pack, with records that withstand review. By the end, you will be able to distinguish a convincing quality system from a logo, compare batch evidence with the label, and identify risks that a product catalogue cannot show.
Key takeaways
- Ask for the manufacturing licence, GMP certificate and inspection history.
- Match batch records against the label for identity, strength and purity.
- Check stability data, storage conditions and sterile-process controls.
- Review delivery performance, complaints and documented corrective actions.
Define reliability before you compare manufacturers
Pharmaceutical-manufacturer reliability means delivering the same declared medicine consistently, not merely holding a GMP certificate. Look for repeatable identity, strength and purity, accurate packaging and labelling, sterility assurance where applicable, dependable delivery, and documented corrective action when something goes wrong.
Assess the legal entity named on the manufacturing licence and purchase documents. A brand owner, marketing-authorisation holder, contract manufacturer and distributor can be different companies. A trusted brand does not prove that its factory is reliable; assess the site that actually receives materials, makes, tests and releases your products.
| Entity | What it controls | Evidence to assess |
|---|---|---|
| Legal manufacturer | Manufacturing, testing and batch release | Licence, site address, dosage-form scope, quality-unit authority and batch records |
| Marketing-authorisation holder | Product approval, specifications and regulatory responsibility | Approval status, approved manufacturer and change-control commitments |
| Distributor or franchise supplier | Ordering, storage and delivery | Supply agreement, storage records, traceability and complaint handling |
For sterile injectables, terminal sterilisation is preferred when the formulation and container tolerate it because it gives stronger sterility assurance than aseptic processing. If aseptic processing is necessary, reliability rests on contamination control across facilities, personnel, utilities, equipment, cleaning, environmental monitoring and interventions—not on a passing sterility test alone.
Also ask whether the independent quality unit can reject materials, packaging, labelling and finished products without commercial override. A manufacturer that cannot show ongoing process verification, supplier monitoring and investigated deviations has a reliability gap, even if its last inspection passed.
Verify the site, certificate and quality system
A licence proves that a site is authorised to manufacture; it does not prove that every product on your quotation falls within that authorisation. Match the legal manufacturer name and factory address before reviewing the certificate.
Request these records for the exact products and dosage forms you plan to buy:
- The manufacturing licence number, licensed site address, dosage forms, and product approval status.
- The GMP certificate or WHO-GMP certificate, including certificate number, issuing authority, inspection date, expiry date, and named manufacturing activities.
- Written certificate scope verification covering the specific product, strength, dosage form, production line, testing, packaging, and storage operations.
Confirm the details with the issuing regulator or its public register, rather than trusting a logo on a brochure. A certificate for tablets does not automatically cover injectables, and a certificate for one factory does not cover another site.
Ask how the quality system proves continued control. Evidence should show process design, process qualification, and continued process verification using routine-production trends; three successful validation batches alone do not establish indefinite control. The quality unit must independently approve or reject materials, labels, batches, and finished products.
If testing, packaging, or distribution is outsourced, require a written quality agreement assigning responsibility for deviations, out-of-specification investigations, batch release, change notification, complaints, audits, records, and regulatory communication. Also review recall records, recurring deviations, CAPA effectiveness, and change-control history.
Use batch records to test what the label promises
A finished medicine is supported by batch-specific evidence, not a generic certificate or an attractive label. Match every record to the product name, strength, batch number, manufacturing date and expiry date printed on the pack.
- The executed batch manufacturing record shows approved instructions, actual quantities, equipment used, operators, in-process checks, yields and recorded deviations.
- The executed packaging record confirms the correct artwork, batch coding, expiry date, leaflet, carton count and line-clearance checks.
- The certificate of analysis lists approved specifications and actual results, including the assay result, identification, purity and microbial limits.
- For dissolution testing tablets, request the results against the stated dissolution specification, not merely a pass/fail summary.
- For injectables, request sterility, bacterial endotoxin and particulate inspection results, with the method, specification and authorised quality-control signatory.
- The batch release record identifies the quality-unit person who reviewed the complete file and approved or rejected release.
- Distribution and reconciliation records connect the batch to shipped quantities, customers and remaining stock.
A missing result, unexplained correction, yield discrepancy or unresolved out-of-specification result is a release warning. Ask for the linked deviation investigation and corrective and preventive action record. If testing, packaging or distribution was outsourced, inspect the quality agreement: it must assign responsibility for records, deviations, batch release, changes, complaints, audits and regulatory communication.
A commercial supply contract alone does not prove traceability.
Check stability, storage and sterile-process controls
An expiry date is credible only when long-term stability studies use the marketed container-closure system at its intended storage temperature, with tests for assay, degradation, appearance, particulate matter, pH and container integrity. Accelerated stability studies reveal weaknesses sooner; they do not replace long-term evidence.
1. Check that the stability file covers the actual injectable presentation, not a different vial, stopper, syringe or formulation. Look for studies at 25°C/60% relative humidity or 30°C/65% relative humidity, plus accelerated studies at 40°C/75% relative humidity where the applicable regulatory framework uses those conditions.
2. Match the labelled storage temperature to the distribution plan. If the product requires refrigeration, ask for defined cold chain requirements, temperature-monitoring records and excursion instructions. A stable medicine can become unsuitable after repeated heat exposure, freezing or light damage.
3. Review process-validation evidence beyond a successful three-batch exercise. The manufacturer should show process design, process qualification and continued process verification, including trend data for assay, fill volume, pH, particulate matter and container-closure integrity.
4. For sterile injectables, confirm whether terminal sterilization is used; it is preferred when the formulation and container tolerate it. If aseptic processing is necessary, inspect evidence covering cleanroom conditions, personnel, utilities, equipment, cleaning, interventions and environmental monitoring. A passing sterility test examines only a sample, so it cannot prove every unit is sterile.
Investigations of adverse trends, repeated deviations and corrective actions demonstrate ongoing control better than a single passing test or certificate.
Judge performance after release and make a defensible choice
A current GMP certificate proves that a site met requirements at an inspection; it does not prove dependable performance over years. Choose the manufacturer that can show dated, anonymised evidence of what happened after release and how problems were closed.
Ask for:
- Complaint handling records showing investigation timelines, medical or product-quality assessment, root cause, and response to recurring complaints.
- Recall traceability demonstrating that the company can identify affected batch numbers, distributors, quantities, and customers from distribution records.
- CAPA effectiveness checks that confirm corrective actions stopped recurrence, rather than merely showing that a CAPA form was closed.
- Change-control records showing advance assessment of changes to materials, suppliers, processes, equipment, packaging, and analytical methods.
- Process-validation trend reviews from routine batches, not only a successful three-batch qualification exercise.
Examine how the quality unit handled an out-of-specification result. A passing repeat test does not erase the original result; the investigation must address laboratory error and manufacturing causes, with a scientifically justified reason if the result is invalidated.
A quality agreement is essential when testing, packaging, distribution, or release is outsourced. It must assign responsibility for deviations, OOS investigations, batch release, change notification, complaints, audits, records, and regulatory communication; a commercial supply contract cannot replace it.
If you are assessing kelps healthcare, apply the same test: ask who can reject a batch, whether commercial staff can override that decision, and what evidence shows the system worked after products reached customers.
Frequently asked questions
What defines a reliable pharmaceutical manufacturer?
Reliability means consistently delivering the declared medicine with correct identity, strength, purity, packaging and labelling, plus dependable delivery and documented corrective action.
Which documents should you verify before choosing a manufacturer?
Request the manufacturing licence, GMP certificate, site details, inspection records and quality-system documents. Confirm that the documents cover the products and dosage forms you plan to source.
How can batch records test what a medicine label promises?
Compare the batch number, manufacturing and expiry dates, test results, specifications, yield, packaging checks and release approval with the product label and certificate of analysis.
What stability and storage evidence should you check?
Review stability data for the labelled shelf life, storage temperature, humidity controls, transport conditions and any special requirements such as refrigeration or protection from light.
How do you assess sterile-process reliability?
Check validated sterilisation or aseptic-processing records, environmental monitoring, media-fill results, sterility testing, container-closure integrity and investigation records for failed tests.
